Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Martin Mackay


  • Director at Charles River Laboratories International Inc. (CRL), 2020-05-12
  • Evp & Global Head Of R&d at Alexion Pharmaceuticals Inc (ALXN), 2017-03-02
  • Senior Vice President at Pfizer Inc (PFE), 2010-05-18
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXN $132.50 370 Officer 50,688 2017-03-01 Filing
ALXN $131.70 625 Officer 38,258 2017-02-28 Filing
ALXN $131.20 860 Officer 38,883 2017-02-27 Filing
ALXN $126.84 217 Officer 39,743 2017-02-09 Filing
ALXN $126.88 18 Officer 39,960 2017-02-06 Filing